1. Home
  2. SVM vs AUTL Comparison

SVM vs AUTL Comparison

Compare SVM & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVM
  • AUTL
  • Stock Information
  • Founded
  • SVM N/A
  • AUTL 2014
  • Country
  • SVM Canada
  • AUTL United Kingdom
  • Employees
  • SVM N/A
  • AUTL N/A
  • Industry
  • SVM Precious Metals
  • AUTL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SVM Basic Materials
  • AUTL Health Care
  • Exchange
  • SVM Nasdaq
  • AUTL Nasdaq
  • Market Cap
  • SVM 663.6M
  • AUTL 590.8M
  • IPO Year
  • SVM N/A
  • AUTL 2018
  • Fundamental
  • Price
  • SVM $3.61
  • AUTL $1.95
  • Analyst Decision
  • SVM Strong Buy
  • AUTL Strong Buy
  • Analyst Count
  • SVM 1
  • AUTL 3
  • Target Price
  • SVM $5.10
  • AUTL $10.20
  • AVG Volume (30 Days)
  • SVM 6.0M
  • AUTL 1.1M
  • Earning Date
  • SVM 02-11-2025
  • AUTL 03-13-2025
  • Dividend Yield
  • SVM 0.70%
  • AUTL N/A
  • EPS Growth
  • SVM 104.66
  • AUTL N/A
  • EPS
  • SVM 0.36
  • AUTL N/A
  • Revenue
  • SVM $266,463,000.00
  • AUTL $10,091,000.00
  • Revenue This Year
  • SVM $35.91
  • AUTL $851.88
  • Revenue Next Year
  • SVM $9.60
  • AUTL $220.57
  • P/E Ratio
  • SVM $10.02
  • AUTL N/A
  • Revenue Growth
  • SVM 28.94
  • AUTL 82.71
  • 52 Week Low
  • SVM $2.34
  • AUTL $1.87
  • 52 Week High
  • SVM $5.32
  • AUTL $6.63
  • Technical
  • Relative Strength Index (RSI)
  • SVM 63.01
  • AUTL 37.49
  • Support Level
  • SVM $3.57
  • AUTL $1.92
  • Resistance Level
  • SVM $3.76
  • AUTL $2.15
  • Average True Range (ATR)
  • SVM 0.16
  • AUTL 0.12
  • MACD
  • SVM 0.04
  • AUTL 0.01
  • Stochastic Oscillator
  • SVM 70.46
  • AUTL 22.22

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is a mineral mining company. It acquires, explores, develops, and mines precious and base metal mineral properties at its producing mines and exploration and development projects in China. The group produces silver, gold, lead, and zinc. The company creates shareholder's value by focusing on generating free cash flow from long-life mines; organic growth through extensive drilling for discovery; equity investments in potential world-class opportunities; ongoing merger and acquisition efforts to unlock value; and long-term commitment to responsible mining and ESG. The Company's producing mines are located in China, and current exploration and development projects are located in China and Mexico.

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Share on Social Networks: